Pear Therapeutics

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

The digital therapeutic company purchased assets from Waypoint Health Innovations and from Örebro University researcher Fredrik Holländare.

The prescription digital therapeutics company said the transaction generated approximately $175 million.

The news comes just as Pear is finalizing its SPAC merger.

Pear announced plans to go public through a merger with a special purpose acquisition company in June, and the deal is set to close soon.

Around two million people receive coverage through Massachusetts' Medicaid program.

The study also found patients in the 24-week group had a 27% decrease in unique hospital encounters compared with the group who only received one prescription.

Using the reSET-O app in addition to other opioid treatments lowered healthcare costs by $1,014 and added 0.003 quality-adjusted life years compared with treatment alone.

Researchers found patients who used reSET-O along with buprenorphine and counseling lowered their healthcare costs by $2,385 per person in the six months after they started using the app, compared with the six months before.

The company said the deal could help it with commercialization and expansion.